Patent · US Active

Interferon α and ω antibody antagonists

US10208113B2 · kind B2 · utility

2Cited by
28References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2015
Grant dateFeb 19, 2019
Priority date
Expiry dateJun 22, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to antibodies that broady neutralize interferon-α and interferon-ω, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.